Pull to refresh
Logo
National Institutes of Health

National Institutes of Health

Federal research agency

Appears in 11 stories

Stories

NIH awards Tufts $6.1 million for Dog Aging Project

Money Moves

Funder of the award

Tufts University has received a $6.1 million federal award to continue the Dog Aging Project, a study of how genetics and environment shape aging in companion dogs. The National Institutes of Health (NIH) obligated the money on September 18, 2026, with research scheduled to start September 30.

Updated Yesterday

HHS launches vaccine injury research and reporting initiative

Rule Changes

Opened the new vaccine injury clinic on its Bethesda campus

The federal government opened a dedicated clinic at the National Institutes of Health this month to study and treat people reporting health problems after vaccination. It's the centerpiece of a new agency-wide push by the Department of Health and Human Services (HHS) to document, investigate, and respond to vaccine injuries. An internal memo obtained by NPR says NIH plans an observational study of vaccinated people and possible complications, and may examine vaccine schedules and treatments.

Updated 2 days ago

Lab-grown brain tissue cracks the psychiatric diagnosis problem

New Capabilities

Funding standardization of organoid technology for drug development

Johns Hopkins engineers grew miniature brains from patients' skin cells and found each psychiatric disorder has its own electrical fingerprint. Using machine learning, the organoids identified schizophrenia and bipolar disorder with 83% accuracy from firing patterns alone, rising to 92% after subtle electric stimulation.

Updated 2 days ago

National Institutes of Health funds UW-Madison neutron capture therapy facility

New Capabilities

Funder

The National Institutes of Health has obligated $8 million to the University of Wisconsin System for a neutron capture therapy research facility in Madison. The award, recorded September 17 with work starting September 18, would give the US its first accelerator-based clinical neutron-beam resource. UW-Madison had already lined up the technology: in September 2025 it agreed with TAE Life Sciences, a California biotech, to install that firm's Alphabeam neutron source.

Updated 2 days ago

Venous disease trials at VEINS 2026 support catheter-based treatments

New Capabilities

Sponsored the C-TRACT randomized trial

Four late-breaking trials at The VEINS 2026 conference in Las Vegas produced new evidence for catheter-based venous disease treatments. The results cover iliac vein stenting for post-thrombotic syndrome, single-session mechanical thrombectomy for deep vein thrombosis, cyanoacrylate closure for venous leg ulcers, and an interim analysis of a pulmonary embolism treatment.

Updated 5 days ago

Study finds humans react faster when exhaling than inhaling

New Capabilities

Funder of the research program

Northwestern University neuroscientists have found that humans react faster when exhaling than when inhaling. In a sustained-attention test with 35 adults, responses during exhalation were on average 41 milliseconds quicker than during inhalation — about 1/25th of a second.

Updated Sep 29

NIH awards Mass General $8.3 million to expand access to experimental ALS drug

Money Moves

Funder of the award

The National Institutes of Health (NIH) awarded $8.3 million to Massachusetts General Hospital to run a program giving ALS patients access to an experimental drug they can't get through clinical trials. The program, called an intermediate-size expanded access protocol (EAP), begins September 1.

Updated Sep 17

Alzheimer's disrupts the 3D folding of DNA in brain cells

New Capabilities

Funder via the 4D Nucleome program

Alzheimer's disease scrambles the three-dimensional folding of DNA inside brain cells, a study published in Science on July 23 reports. It's the first single-cell map of how the disease reshapes the genome's architecture across the brain.

Updated Sep 13

Drug Farm advances first potential therapy for rare ROSAH syndrome

New Capabilities

Research partner for DF-003 ROSAH development

A few dozen families worldwide carry a gene mutation that slowly steals their sight and floods their bodies with inflammation. On July 13, 2026, Drug Farm announced it raised $55 million to push its candidate for that disease, ROSAH syndrome, into a Phase 3 trial.

Updated Jul 14

Reshaping federal health leadership

Rule Changes

Operating under Director Jay Bhattacharya since April 2025

Jay Bhattacharya co-authored the Great Barrington Declaration in October 2020, publicly opposing the Centers for Disease Control and Prevention's pandemic response policies. Five years later, he now controls both the CDC and the National Institutes of Health—the two largest federal public health agencies—making him the most powerful health official in America outside the cabinet.

Updated May 29

Congress rejects Trump's historic science cuts

Rule Changes

Appropriations bill provides $48.7B, a $415M increase over FY2025

For 80 years, federal science funding enjoyed bipartisan protection. Trump's fiscal year 2026 budget proposed ending that consensus, calling for cuts of 57% to the National Science Foundation (NSF), 47% to NASA's science programs, and 40% to the National Institutes of Health (NIH).

Updated May 23